Payment overview · 2025
General Payments
$67.49
3 reported records · 2 companies
Healthcare provider profile · identity verified
Luis C Pannocchia, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · NEW TAZEWELL, TN · NPI 1912988965
Verified facts
What the public records show
CMS Open Payments records show Luis C Pannocchia, M.D. received $67.49 in general payments during 2025 across 3 reported records.
ABBVIE INC. accounted for 65.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $44.02 | 65.2% | 2 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $23.47 | 34.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $67.49 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $44.02 | 2 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.47 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 942 | 154 |
| Eliquis | Apixaban | 913 | 99 |
| Atorvastatin Calcium | Atorvastatin Calcium | 899 | 191 |
| Gabapentin | Gabapentin | 644 | 93 |
| Furosemide | Furosemide | 612 | 110 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 604 | 101 |
| Potassium Chloride | Potassium Chloride | 495 | 108 |
| Amlodipine Besylate | Amlodipine Besylate | 492 | 135 |
| Famotidine | Famotidine | 487 | 132 |
| Metoprolol Tartrate | Metoprolol Tartrate | 480 | 100 |
| Benazepril Hcl | Benazepril Hcl | 449 | 98 |
| Sertraline Hcl | Sertraline Hcl | 447 | 95 |
| Omeprazole | Omeprazole | 445 | 132 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 389 | 109 |
| Losartan Potassium | Losartan Potassium | 359 | 86 |
| Tamsulosin Hcl | Tamsulosin Hcl | 355 | 80 |
| Lisinopril | Lisinopril | 352 | 82 |
| Pantoprazole Sodium | Pantoprazole Sodium | 314 | 77 |
| Prednisone | Prednisone | 280 | 159 |
| Trazodone Hcl | Trazodone Hcl | 272 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 261 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 259 | 60 |
| Montelukast Sodium | Montelukast Sodium | 252 | 57 |
| Divalproex Sodium | Divalproex Sodium | 228 | 32 |
| Metformin Hcl | Metformin Hcl | 225 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 208 | 47 |
| Alprazolam | Alprazolam | 207 | 31 |
| Lorazepam | Lorazepam | 194 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 184 | 70 |
| Hydralazine Hcl | Hydralazine Hcl | 183 | 49 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 177 | 59 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 175 | 34 |
| Metformin Hcl Er | Metformin Hcl | 170 | 55 |
| Citalopram Hbr | Citalopram Hydrobromide | 152 | 34 |
| Januvia | Sitagliptin Phosphate | 149 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 149 | 27 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 146 | 32 |
| Levetiracetam | Levetiracetam | 145 | 18 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 144 | 33 |
| Glimepiride | Glimepiride | 142 | 40 |
| Carvedilol | Carvedilol | 141 | 35 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 139 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 136 | 23 |
| Atenolol | Atenolol | 131 | 32 |
| Farxiga | Dapagliflozin Propanediol | 120 | 23 |
| Tramadol Hcl | Tramadol Hcl | 120 | 41 |
| Pregabalin | Pregabalin | 117 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 20 |
| Meloxicam | Meloxicam | 115 | 39 |
| Donepezil Hcl | Donepezil Hcl | 114 | 25 |
| Buspirone Hcl | Buspirone Hcl | 112 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 110 | 23 |
| Cefdinir | Cefdinir | 107 | 81 |
| Ozempic | Semaglutide | 103 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 99 | 27 |
| Megestrol Acetate | Megestrol Acetate | 94 | 26 |
| Amiodarone Hcl | Amiodarone Hcl | 92 | 16 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 90 | 63 |
| Diazepam | Diazepam | 90 | 14 |
| Paroxetine Hcl | Paroxetine Hcl | 88 | 14 |
| Bumetanide | Bumetanide | 86 | 27 |
| Baclofen | Baclofen | 85 | 24 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 81 | 14 |
| Ezetimibe | Ezetimibe | 79 | 28 |
| Simvastatin | Simvastatin | 79 | 25 |
| Levofloxacin | Levofloxacin | 78 | 59 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 26 |
| Ropinirole Hcl | Ropinirole Hcl | 76 | 20 |
| Morphine Sulfate Er | Morphine Sulfate | 74 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 73 | 28 |
| Ibuprofen | Ibuprofen | 72 | 35 |
| Warfarin Sodium | Warfarin Sodium | 72 | 15 |
| Allopurinol | Allopurinol | 71 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 71 | 50 |
| Jardiance | Empagliflozin | 70 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 68 | 16 |
| Xarelto | Rivaroxaban | 68 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 67 | 17 |
| Trulicity | Dulaglutide | 66 | 11 |
| Bupropion Xl | Bupropion Hcl | 63 | 20 |
| Tradjenta | Linagliptin | 60 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | 17 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 58 | 13 |
| Alendronate Sodium | Alendronate Sodium | 57 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 57 | 16 |
| Mirtazapine | Mirtazapine | 57 | 15 |
| Risperidone | Risperidone | 57 | suppressed |
| Myrbetriq | Mirabegron | 52 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 52 | 11 |
| Ondansetron Odt | Ondansetron | 50 | 33 |
| Mounjaro | Tirzepatide | 49 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 40 |
| Sucralfate | Sucralfate | 48 | suppressed |
| Valsartan | Valsartan | 48 | suppressed |
| Spironolactone | Spironolactone | 47 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 45 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Fluconazole | Fluconazole | 44 | 29 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 44 | 36 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 43 | 21 |
| Ramipril | Ramipril | 43 | suppressed |
| Celecoxib | Celecoxib | 40 | 12 |
| Tresiba Flextouch U-200 | Insulin Degludec | 40 | suppressed |
| Fenofibrate | Fenofibrate | 39 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 39 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 38 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 38 | 17 |
| Ketoconazole | Ketoconazole | 37 | 28 |
| Lansoprazole | Lansoprazole | 36 | suppressed |
| Olanzapine | Olanzapine | 36 | suppressed |
| Acyclovir | Acyclovir | 34 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Colchicine | Colchicine | 33 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 32 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 32 | 18 |
| Diclofenac Sodium | Diclofenac Sodium | 32 | 11 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 32 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 31 | 26 |
| Gemtesa | Vibegron | 31 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Metronidazole | Metronidazole | 31 | 26 |
| Nystatin | Nystatin | 31 | 21 |
| Azithromycin | Azithromycin | 30 | 27 |
| Clonazepam | Clonazepam | 30 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 30 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 30 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 29 | suppressed |
| Methocarbamol | Methocarbamol | 29 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 29 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 29 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Lactulose | Lactulose | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | 16 |
| Amoxicillin | Amoxicillin | 27 | 24 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 26 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 26 | 16 |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Metolazone | Metolazone | 26 | suppressed |
| Mupirocin | Mupirocin | 26 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 26 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 26 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 26 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 25 | 13 |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Prolia | Denosumab | 25 | 20 |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 24 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 24 | suppressed |
| Eszopiclone | Eszopiclone | 24 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Estradiol | Estradiol | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | suppressed |
| Synthroid | Levothyroxine Sodium | 22 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Nyamyc | Nystatin | 21 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Primidone | Primidone | 20 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 19 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Meropenem | Meropenem | 19 | 11 |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 18 | 14 |
| Nitroglycerin | Nitroglycerin | 18 | 13 |
| Theophylline Er | Theophylline Anhydrous | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 17 | suppressed |
| Pen Needles | Pen Needle, Diabetic | 17 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | 14 |
| Breyna | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Clonidine | Clonidine | 15 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 15 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | 14 |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Meropenem-0.9% Nacl | Meropenem-0.9% Sodium Chloride | 15 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Amantadine | Amantadine Hcl | 14 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 14 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 13 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 13 | suppressed |
| Lyrica | Pregabalin | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Xanax | Alprazolam | 13 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 12 | suppressed |
| Dulera | Mometasone/Formoterol | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Latuda | Lurasidone Hcl | 12 | suppressed |
| Levemir Flexpen | Insulin Detemir | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Novolog Mix 70-30 | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Cholestyramine Light | Cholestyramine | 11 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Niacin Er | Niacin | 11 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | suppressed |
| Paliperidone Er | Paliperidone | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $67.49 · 3 records | ABBVIE INC. | CAPLYTA, VRAYLAR | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error